<bill session="116" type="h" number="8588" updated="2020-12-22T14:51:37Z">
  <state datetime="2020-10-13">REFERRED</state>
  <status>
    <introduced datetime="2020-10-13"/>
  </status>
  <introduced datetime="2020-10-13"/>
  <titles>
    <title type="display">Improving the American Drug Supply Chain Act of 2020</title>
    <title type="short" as="introduced">Improving the American Drug Supply Chain Act of 2020</title>
    <title type="official" as="introduced">To provide for a study on the current and historical production of drugs in the United States and in foreign countries, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="H001067"/>
  <cosponsors>
    <cosponsor bioguide_id="B001303" joined="2020-10-13"/>
  </cosponsors>
  <actions>
    <action datetime="2020-10-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-10-13" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-10-13">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSFA" name="House Foreign Affairs" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="14"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Economic performance and conditions"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Emergency planning and evacuation"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Intellectual property"/>
    <term name="Labor market"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2020-10-13T04:00:00Z" status="Introduced in House">Improving the American Drug Supply Chain Act of 2020

This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.</summary>
  <committee-reports/>
</bill>
